ConductScience.org, home

Paper10073740

The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.

Gisleskog PO and 3 others. Br J Clin Pharmacol, 1999. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination. Papers, record 10073740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073740

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1999
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.19
iCite
Revised in PubMed
2019-05-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gisleskog POP O
2Hermann DD
3Hammarlund-Udenaes MM
4Karlsson MOM O

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AzasteroidsMajor topic
Enzyme InhibitorsMajor topic
OxidoreductasesMajor topic
Adult
Dose-Response Relationship, Drug
Drug Administration Schedule
Dutasteride
Half-Life
Humans
Male
Middle Aged
Models, Biological
Placebos
Single-Blind Method

Source PubMed

Download CSV of topics

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11714529High prevalence of benign prostatic hypertrophy in the community.Lancet1991https://conductscience.org/library/papers/1714529PubMed
21383817Is the prostate pill finally here?N Engl J Med1992https://conductscience.org/library/papers/1383817PubMed
37979239Steroid 5 alpha-reductase: two genes/two enzymes.Annu Rev Biochem1994https://conductscience.org/library/papers/7979239PubMed
49871428A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.Clin Pharmacol Ther1998https://conductscience.org/library/papers/9871428PubMed
58575497Proscar: five-year experience.Eur Urol1995https://conductscience.org/library/papers/8575497PubMed
69316864Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR.J Pharmacol Exp Ther1997https://conductscience.org/library/papers/9316864PubMed
77577933Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies.Biochemistry1995https://conductscience.org/library/papers/7577933PubMed

Download CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
41501168SRD5A2 and emerging therapies in androgen-driven disorders.Nat Rev Urol2026https://conductscience.org/library/papers/41501168PubMed
41366580Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics.AAPS J2025https://conductscience.org/library/papers/41366580PubMed
39641480Topical dutasteride for androgenic alopecia: current state and prospects.Ther Deliv2025https://conductscience.org/library/papers/39641480PubMed
37554681Combination and Rotational Therapy in Androgenetic Alopecia.J Cutan Aesthet Surg2023https://conductscience.org/library/papers/37554681PubMed
30588787Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment.World J Mens Health2019https://conductscience.org/library/papers/30588787PubMed
29907425Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats.Neuropharmacology2019https://conductscience.org/library/papers/29907425PubMed
25281165Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry.Talanta2015https://conductscience.org/library/papers/25281165PubMed
248234645α-reductase type 1 modulates insulin sensitivity in men.J Clin Endocrinol Metab2014https://conductscience.org/library/papers/24823464PubMed
24615171Pharmacokinetic bioequivalence studies of a fixed-dose combination of tamsulosin and dutasteride in healthy volunteers.Clin Drug Investig2014https://conductscience.org/library/papers/24615171PubMed
24557088Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment.Psychopharmacology (Berl)2014https://conductscience.org/library/papers/24557088PubMed
23737668Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.Int J Nanomedicine2013https://conductscience.org/library/papers/23737668PubMed
22970204A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance.PLoS One2012https://conductscience.org/library/papers/22970204PubMed
22044402Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects.Br J Clin Pharmacol2012https://conductscience.org/library/papers/22044402PubMed
16783479Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B4 synthesis inhibitor.Pharm Res2006https://conductscience.org/library/papers/16783479PubMed
14565784Dutasteride.Drugs Aging2003https://conductscience.org/library/papers/14565784PubMed
12934061Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life.Int J Impot Res2003https://conductscience.org/library/papers/12934061PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10073740

GET https://conductscience.org/api/papers/v1/10073740/authors